Administration of Mesenchymal Stem Cells in Diabetic Kidney Disease: Mechanisms, Signaling Pathways, and Preclinical Evidence

The authors provide an unbiased review of recent advances in MSCs for the treatment of diabetic kidney disease (DKD) in the last decade from the perspectives of the pathogenesis of DKD, biological characteristics of MSCs, and different molecular and signaling pathways.